2019
DOI: 10.15283/ijsc18133
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal Stem Cell Transplantation Promotes Functional Recovery through MMP2/STAT3 Related Astrogliosis after Spinal Cord Injury

Abstract: Background and Objectives Treatment with mesenchymal stem cells (MSC) in spinal cord injury (SCI) has been highlighted as therapeutic candidate for SCI. Although astrogliosis is a major phenomenon after SCI, the role of astrogliosis is still controversial. In this study, we determined whether acute transplantation of MSC improves the outcome of SCI through modulating astrogliosis. Methods Bone marrow derived rat MSCs were induced neural differentiation and transplanted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
13
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(13 citation statements)
references
References 34 publications
0
13
0
Order By: Relevance
“…It should be noted that MFs can be coated with very different combinations of proteins and thus offer an extensive therapeutic flexibility. Besides proteins associated to cell adhesion and growth factors, the MF coating could also provide modulators of molecular pathways involved in intrinsic growth, thereby extending the range of manipulation of the local environment, especially at early time points [ 33 , 34 , 35 , 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…It should be noted that MFs can be coated with very different combinations of proteins and thus offer an extensive therapeutic flexibility. Besides proteins associated to cell adhesion and growth factors, the MF coating could also provide modulators of molecular pathways involved in intrinsic growth, thereby extending the range of manipulation of the local environment, especially at early time points [ 33 , 34 , 35 , 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…STAT3 is activated following SCI and plays a vital role in the differentiation and organization of astrocytes (43), which contribute to glial scar formation (22,38,39). In addition, according to previous studies, the microenvironment surrounding the spinal cord lesion site following SCI result in the differentiation of exogenous NSCs into astrocytes (28,44,45). This leads to the formation of glial scars in the lesion site that are widely regarded to inhibit axon regeneration and functional recovery during the chronic phase of SCI (17,46,47).…”
Section: Discussionmentioning
confidence: 96%
“…STAT3 is a member of the JAK-STAT signaling family that transduces signals for many cytokines, and growth factors, including IL-6, ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), EGF, and transforming growth factor α (TGFα), have been implicated as triggers of reactive astrogliosis [22]. STAT3 is active after SCI and plays a vital role in the differentiation of astrocytes, which contributes to glial scar formation [19,23]. STAT3 inhibitors have been shown to reverse the inhibitory effect of STAT3 on neuronal recovery [24].…”
Section: Discussionmentioning
confidence: 99%